ZA201900719B - Solid composition containing oral anticoagulant - Google Patents
Solid composition containing oral anticoagulantInfo
- Publication number
- ZA201900719B ZA201900719B ZA2019/00719A ZA201900719A ZA201900719B ZA 201900719 B ZA201900719 B ZA 201900719B ZA 2019/00719 A ZA2019/00719 A ZA 2019/00719A ZA 201900719 A ZA201900719 A ZA 201900719A ZA 201900719 B ZA201900719 B ZA 201900719B
- Authority
- ZA
- South Africa
- Prior art keywords
- composition containing
- solid composition
- containing oral
- oral anticoagulant
- anticoagulant
- Prior art date
Links
- 239000003146 anticoagulant agent Substances 0.000 title 1
- 239000008247 solid mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201641023129 | 2016-07-05 | ||
| PCT/IB2017/054031 WO2018007945A1 (en) | 2016-07-05 | 2017-07-04 | Solid composition containing oral anticoagulant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201900719B true ZA201900719B (en) | 2022-02-23 |
Family
ID=60912395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2019/00719A ZA201900719B (en) | 2016-07-05 | 2019-02-04 | Solid composition containing oral anticoagulant |
Country Status (4)
| Country | Link |
|---|---|
| BR (1) | BR112019000187A2 (en) |
| CA (1) | CA3028346A1 (en) |
| WO (1) | WO2018007945A1 (en) |
| ZA (1) | ZA201900719B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1009619B (en) * | 2018-05-09 | 2019-10-23 | Φαρμαζακ Α.Φ.Ε.Β.Ε. | Pharmaceutical composition containing rivaroxaban and method for the preparation thereof |
| WO2022259118A1 (en) * | 2021-06-10 | 2022-12-15 | Shilpa Medicare Limited | Fast dissolving oral film preparation comprising rivaroxaban |
| WO2023067620A1 (en) * | 2021-10-18 | 2023-04-27 | Unison Pharmaceuticals Pvt. Ltd. | Orally disintegrating pharmaceutical compositions of rivaroxaban |
| CN116327726B (en) * | 2023-02-24 | 2024-02-02 | 沈阳药科大学 | Platelet membrane coated bionic nano-particle and preparation method and application thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10355461A1 (en) * | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases |
| DE102004062475A1 (en) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Solid, orally administrable, modified release pharmaceutical dosage forms |
| US20110300214A1 (en) * | 2008-07-08 | 2011-12-08 | Ratiopharm Gmbh | Pharmaceutical compositions comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid |
| CA2733611A1 (en) * | 2008-08-11 | 2010-02-18 | Ratiopharm Gmbh | Pharmaceutical compositions with modified release properties comprising 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
| ES2606127T5 (en) * | 2009-06-18 | 2020-02-17 | Krka Tovarna Zdravil D D Novo Mesto | Solid pharmaceutical composition comprising rivaroxaban |
-
2017
- 2017-07-04 WO PCT/IB2017/054031 patent/WO2018007945A1/en not_active Ceased
- 2017-07-04 BR BR112019000187A patent/BR112019000187A2/en not_active IP Right Cessation
- 2017-07-04 CA CA3028346A patent/CA3028346A1/en not_active Abandoned
-
2019
- 2019-02-04 ZA ZA2019/00719A patent/ZA201900719B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112019000187A2 (en) | 2019-04-24 |
| CA3028346A1 (en) | 2018-01-11 |
| WO2018007945A1 (en) | 2018-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3513809T (en) | Medicinal composition | |
| ZA201807730B (en) | An oral care composition | |
| EP3108868A4 (en) | Dental restorative composition | |
| GB201601572D0 (en) | NO containing compositions | |
| GB201621987D0 (en) | Novel composition | |
| LT3278801T (en) | Pharmaceutical composition containing mirabegron | |
| ZA201902622B (en) | Oral care composition | |
| ZA201902623B (en) | Oral care composition | |
| ZA201900719B (en) | Solid composition containing oral anticoagulant | |
| GB201600075D0 (en) | Immunogenci composition | |
| GB2543417B (en) | An oral particulate composition | |
| GB201621685D0 (en) | Novel composition | |
| SG11201702334SA (en) | External preparation composition containing s-flurbiprofen | |
| EP3510990A4 (en) | Oral composition | |
| SG11201710708VA (en) | Oral composition | |
| SG11201708597VA (en) | Oral care composition | |
| EP3156038B8 (en) | Oral composition | |
| IL266859A (en) | Solid oral composition containing dyes | |
| GB201512023D0 (en) | Dental compositions | |
| ZA201903378B (en) | Oral care composition | |
| IL249151A0 (en) | Oral composition | |
| GB201620701D0 (en) | Novel composition | |
| GB201703483D0 (en) | Dental compositions | |
| GB201515824D0 (en) | Oral composition | |
| PL3329939T3 (en) | Abuse-proof solid pharmaceutical composition |